HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Paul S Cederna Selected Research

Tenotomy

11/2015The Systemic Effect of Burn Injury and Trauma on Muscle and Bone Mass and Composition.
1/2015Effects of aging on osteogenic response and heterotopic ossification following burn injury in mice.
1/2015Direct Mouse Trauma/Burn Model of Heterotopic Ossification.
9/2014Treatment of heterotopic ossification through remote ATP hydrolysis.
5/2013Early detection of burn induced heterotopic ossification using transcutaneous Raman spectroscopy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Paul S Cederna Research Topics

Disease

9Burns
11/2015 - 02/2010
9Wounds and Injuries (Trauma)
09/2015 - 05/2002
2Anoxia (Hypoxia)
02/2015 - 01/2014
2Contracture
09/2014 - 01/2014
2Cicatrix (Scar)
01/2014 - 01/2014
2Necrosis
01/2014 - 01/2014
2Congenital Abnormalities (Deformity)
02/2010 - 11/2007
2Atrophy
01/2007 - 07/2004
1Muscular Atrophy (Muscle Atrophy)
11/2015
1Hyperemia
09/2015
1Obesity
03/2015
1Stroke (Strokes)
03/2015
1Heterotopic Ossification (Ectopic Ossification)
09/2014
1Inflammation
01/2014
1Hernia (Hernias)
01/2014
1Osteomyelitis
04/2013
1Ulcer
04/2013
1Venous Thromboembolism
06/2012
1Migraine Disorders (Migraine)
03/2012
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2011
1Colorectal Neoplasms (Colorectal Cancer)
10/2011
1Poland Syndrome
11/2007
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
11/2004

Drug/Important Bio-Agent (IBA)

2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015 - 01/2014
2Apyrase (ATP Diphosphatase)IBA
09/2014 - 01/2014
2Adenosine Triphosphate (ATP)IBA
09/2014 - 01/2014
2salicylhydroxamic acid (SHAM)IBA
05/2014 - 05/2013
2PlasticsIBA
03/2012 - 11/2007
1EnzymesIBA
11/2015
1tranilast (N 5')IBA
09/2015
1suralIBA
09/2015
1Vascular Endothelial Growth Factor BIBA
02/2015
1Messenger RNA (mRNA)IBA
02/2015
1NF-kappa B (NF-kB)IBA
01/2015
1AdenosineFDA LinkGeneric
09/2014
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
09/2014
1First StepIBA
05/2014
1aniline blueIBA
05/2014
1safranine T (safranin)IBA
05/2014
1C.I. direct red 80IBA
05/2014
1matrigelIBA
01/2014
1RNA (Ribonucleic Acid)IBA
01/2014
1Anti-Bacterial Agents (Antibiotics)IBA
04/2013

Therapy/Procedure

5Tenotomy
11/2015 - 05/2013
3Denervation
11/2008 - 07/2004
2Debridement
04/2013 - 06/2008
2Tissue Expansion
02/2010 - 02/2008
2Tissue Expansion Devices (Tissue Expander)
02/2010 - 03/2007
1Leeching
09/2015
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2015
1Transplants (Transplant)
03/2015
1Blood Transfusion (Blood Transfusions)
03/2015
1Therapeutics
09/2014
1Implanted Electrodes
01/2014
1Muscle Denervation
01/2014
1Activities of Daily Living (ADL)
01/2014
1Electrodes (Electrode)
01/2014
1Ambulatory Surgical Procedures (Outpatient Surgery)
06/2012
1Patient Positioning
10/2011
1Nerve Transfer
11/2008
1Negative-Pressure Wound Therapy
06/2008
1Limb Salvage
11/2004
1Free Tissue Flaps
05/2002